| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374889A1 Method of inducing angiogenesis by micro-organs |
| 01/02/2004 | EP1374879A1 Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 01/02/2004 | EP1374874A2 Liquid antacid compositions |
| 01/02/2004 | EP1374863A1 Amino acid compositions for ameliorating liver failure |
| 01/02/2004 | EP1373543A2 Method for producing pectin hydrolysis products |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373485A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 01/02/2004 | EP1373478A1 Attenuated live vaccine |
| 01/02/2004 | EP1373475A2 Immunotherapy based on dendritic cells |
| 01/02/2004 | EP1373319A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373262A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373257A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/02/2004 | EP1373256A1 Ccr5 antagonists useful for treating aids |
| 01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
| 01/02/2004 | EP1373249A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 01/02/2004 | EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373216A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372720A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 01/02/2004 | EP1372700A1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 01/02/2004 | EP1372697A2 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c, and corresponding screening method |
| 01/02/2004 | EP1372696A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372679A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372675A2 Ionene polymers and their use as antimicrobial agents |
| 01/02/2004 | EP1372673A2 The use of non-digestible polymeric foams to sequester ingested materials, thereby inhibiting their absorption by the body |
| 01/02/2004 | EP1372664A1 Use of certain steroids for treatment of blood cell deficiencies |
| 01/02/2004 | EP1372661A2 Methods of treating irritable bowel syndrome and functional dyspepsia |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372650A2 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372617A2 Enteric ketoacid salts and amino acids and their use for preparing medicines |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP1250146B1 Use of botulinum toxins for treating diabetes |
| 01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
| 01/02/2004 | EP1204595B1 Polytype mg-ai hydrotalcite |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002534 Stem cell factor; signal transduction passageways; anticancer agents |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002511 Novel pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002449 METH1 and METH2 polynucleotides and polypeptides |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |
| 01/01/2004 | US20040001895 Combination treatment for depression and anxiety |
| 01/01/2004 | US20040001881 Drug in pressure sensitive adhesive; vomiting, nausea therapy; side effect reduction |
| 01/01/2004 | US20040001842 Inducing antibodies in situ; binding; antitumor agents, anticancer agents |
| 01/01/2004 | US20040001811 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 12/31/2003 | WO2004001655A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 12/31/2003 | WO2004001048A1 Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 12/31/2003 | WO2004001023A2 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 12/31/2003 | WO2004001022A1 Probiotic propionibacterium jensenii 702 |
| 12/31/2003 | WO2004001020A2 Methods and means to promote gut absorption |
| 12/31/2003 | WO2004000887A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 12/31/2003 | WO2004000878A1 Immunogenic polypeptide isolated from Mycobacterium avium subspecies paratuberculosis and uses thereof |
| 12/31/2003 | WO2004000856A1 Combination of a reflux inhibitor and an imidazopyridine for the treatment of gerd |
| 12/31/2003 | WO2004000855A1 Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd |
| 12/31/2003 | WO2004000854A1 Sulfur-containing phospholipid derivatives |
| 12/31/2003 | WO2004000849A2 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 12/31/2003 | WO2004000846A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 12/31/2003 | WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
| 12/31/2003 | WO2004000839A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |